Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Breast Cancer in Ardabil Province in the North-West of Iran: an Epidemiological Study

  • Published : 2012.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Breast cancer accounts for about 26% of all newly diagnosed cancers in women aged 20 to 59 years. As part of a basic program for cancer control, the present cross sectional descriptive study was conducted with the objective of determining the epidemiology of breast cancer in Ardabil province during 2003-2010. Necessary information on 469 recorded cases of breast cancer in the registry were collected by check list from patient's files and then analyzed by statistical methods with SPSS.16 software. Some 455 of the patients (97%) were female, 329 (70.1%) residing in Ardabil. The mean age was $46.8{\pm}13.6$ and most were in the age group of 40 - 60. The most prevalent pathologic form was infiltrative ductal carcinoma with 316 cases (67.4%), the largest proportion being grade II (30.6%), but very many belonged to grades III and IV (40.5%). Breast cancer in Ardabil province appeared to slightly increase over the period studied. The results were similar to other places in Asia. With regard to this, more widespread studies are required to determine factors influencing the prevalence at low age and also how to promote early detection.

Keywords

References

  1. Anderson BO, Jakesz R (2008). Breast cancer issues in developing countries: an overview of the Breast Health Global Initiative. World J Surg, 32, 2578-85. https://doi.org/10.1007/s00268-007-9454-z
  2. Ayadi L, Khabir A, Amouri H, et al (2008). Correlation of HER- 2 over- expression with clinic - pathological parrameters in Tunisian breast carcinoma. World J Surg Oncol, 22, 112-4.
  3. Babaei M, Jaafarzadeh H, Sadjadi AR, et al (2009). Cancer Incidence and Mortality in Ardabil: Report of an Ongoing Population-Based Cancer Registry in Iran, 2004-2006. Iranian J Publ Health, 38, 35-45.
  4. Bakhtiari A, Haj- Ahmadi M (2006). 5 year assessment of breast cancer at Rajaii hospital, Baboolsar (1991-1996). The Iranian Journal of obstetrics, Gynecology & Infertility, 9, 47-52.
  5. Brunicardi FC, Schwartz SI (2010). Schwartz's principles of surgery. MC Graw Hill press, New York pp 424-69.
  6. Fouladi N, Amani F, Sharghi A, et al (2011). Five year survival of women with breast cancer in Ardabil. APJCP, 12, 1799-801.
  7. Goya M (2007). Iranian Annual Cancer Registration Report 2005/2006. Ministry of Health and Medical Education, Health Deputy, Center for Disease Control and Prevention (In Persian). Tehran, Iran.
  8. Hill T, Khamis H (2005). Comparison of Male and Female Breast Cancer Incidence Trends, Tumor Characteristics, and Survival. AEP, 15, 773-80.
  9. Hoel DG, Wakabayashi T, Pike MC (1983). Secular trends in the distributions of the breast cancer risk factors-menarche, first birth, menopause, and weight - in Hiroshima and Nagasaki, Japan. Am J Epidemiol, 118, 78-89.
  10. Mousavi SM, Gouya MM, Ramazani R, et al (2009). Cancer incidence and mortality in Iran. Ann Oncol, 20, 556-63.
  11. Mousavi SM, Gouya MM, Ramazani R (2009). Cancer incidence and mortality in Iran. Ann Oncol, 20, 556-63.
  12. Mousavi M (2009). Age distribution of breast cancer in the middle east, implications for screening. The Breast J, 15, 677-9. https://doi.org/10.1111/j.1524-4741.2009.00843.x
  13. Norsaadah B, Rusli BN, Imran AK, et al (2005). Risk factors of breast cancer in women in Kelantan, Malaysia. Singapore Med J, 46, 698-705.
  14. Parkin DM, Bray F, Ferlay J (2005). Global cancer statistics 2002. CA Cancer J Clin, 55, 74-108. https://doi.org/10.3322/canjclin.55.2.74
  15. Peto R, Boreham J, Clarke M (2000). UK and USA breast cancer deaths doen 25% in year 2000 at age 20-69 years. Lancet, 355, 1822-4.
  16. Sadjadi A, Nouraie M, Mohagheghi MA (2005). Cancer occurrence in Iran in 2002: an international perspective. APJCP, 6, 359-63
  17. Sadjadi A, Malekzadeh R, Derakhshan MH, et al (2003). Cancer Occurrence In Ardabil: Results Of A Population-Based Cancer Registry from Iran. Int J Cancer, 107, 113-8.
  18. Sadjadi A, Nouraie M, Hislop T, et al (2009). Comparison of breast cancer survival in two populations: Ardabil and British Columbia. BMC Cancer, 28, 381-6.
  19. The Top 10 Causes of Death in 2004, Fact Sheet of WHO Report. World Health Organization, 2008.
  20. Townsend CM, Sabiston DC (2004). Sabiston textbook of surgery. Elsevier Saunders press, Philadelphia , pp 867-946.
  21. Yaghmayee S, Bani-Hashemi G, Gorbani R (2007). The investigation of survival rate and some factors affecting it in female breast cancer sufferers who had undergone surgery in Emdad Hospital of Semnan during 1991- 2002: Regression- Cox application. Sci J Semnan University Med Sci, 9, 111-5.
  22. Zafarghandi A, Harirchi I, Ebrahimi M, et al (1998). Breast cancer in Iran: A review of pathological records. J Tehran Faculty of Med, 56, 42-7.

Cited by

  1. Beliefs and Behaviors of Breast Cancer Screening in Women Referring to Health Care Centers in Northwest Iran According to the Champion Health Belief Model Scale vol.14, pp.11, 2013, https://doi.org/10.7314/APJCP.2013.14.11.6857
  2. Overview of Cancer Registration Research in the Asian Pacific from 2008-2013 vol.14, pp.8, 2013, https://doi.org/10.7314/APJCP.2013.14.8.4461
  3. Exploratory Study of Factors Affecting Continuity of Cancer Care: Iranian Women's Perceptions vol.15, pp.1, 2014, https://doi.org/10.7314/APJCP.2014.15.1.133
  4. Psychometric Properties of the Persian Version of the Self-Assessed Support Needs Questionnaire for Breast Cancer Cases vol.15, pp.3, 2014, https://doi.org/10.7314/APJCP.2014.15.3.1435
  5. Trends of Breast Cancer Incidence in Iran During 2004-2008: A Bayesian Space-time Model vol.15, pp.4, 2014, https://doi.org/10.7314/APJCP.2014.15.4.1557
  6. Sexual life after mastectomy in breast cancer survivors: A qualitative study pp.10579249, 2017, https://doi.org/10.1002/pon.4479
  7. An infodemiology study on breast cancer in Iran vol.36, pp.2, 2018, https://doi.org/10.1108/EL-03-2017-0062